Used as a chiral intermediate in the synthesis of pharmaceutical agents, particularly in the development of kinase inhibitors. Its oxazoline core with a stereogenic center enables selective binding to enzyme targets, enhancing drug potency and reducing off-target effects. Commonly employed in oncology drug research due to its ability to modulate signaling pathways involved in cell proliferation. Also utilized in asymmetric catalysis for the preparation of enantiomerically pure compounds in medicinal chemistry.